Navigation Links
DNA Genotek Partners with Roswell Park Cancer Institute to Accelerate Breast Cancer Research

DNA Genotek to Provide Method for Easy, Reliable and Non-Invasive DNA Collection On-Site at Komen Western New York Race for the Cure®

Ottawa, ON (PRWEB) June 12, 2009 -- DNA Genotek, a leading provider of products for biological sample collection, today announced that it has partnered with the Roswell Park Cancer Institute (RPCI) to collect DNA saliva samples on-site at the Susan G. Komen Western New York Race for the Cure®. The race will be held this June 13th at the Delaware Park Rose Gardens in Buffalo, NY.

This event is the second of its kind under the "Spit for the Cure"™ umbrella and joins the very successful event initiated in 2007 by DNA Genotek, the Arkansas Affiliate of the Susan G. Komen for the Cure, and the University of Arkansas for Medical Sciences. Thousands of DNA samples have been collected at the Arkansas event.

The Komen Western New York Race for the Cure presents another excellent opportunity to accelerate breast cancer research. With more than 5,000 race participants expected, it will provide access to ideal candidates who satisfy donor profile requirements. The samples collected will become part of RPCI's Data Bank and BioRepository (DBBR) and used to augment cancer research.

Oragene®•DNA solves DNA sample collection problems inherent with traditional collection methods. Among many issues, traditional methods are too costly and invasive, or they do not reliably provide enough high quality DNA to enable health researchers to determine the underlying genetic cause of diseases like cancer, heart disease, and diabetes. In contrast, Oragene•DNA offers easy and non-invasive self-collection of saliva samples from large numbers of people. In addition, Oragene•DNA delivers high quality DNA that is stable at ambient temperature for years.

"The success of the initial Spit for the Cure event in Arkansas gave us the idea to recruit donor participants during the Western New York Race for the Cure to increase our bank of genetic samples", said Christine Ambrosone, PhD, Director, Data Bank and BioRepository, Roswell Park Cancer Institute". These genetic samples will allow us to further investigate the underlying genetic causes of breast cancer with the goal to improve diagnosis, assist prognosis and identify specific targets for therapeutic intervention. Participants will be enthusiastic about using Oragene•DNA to contribute a sample once they know it is easy, non-invasive and has the vast potential to unlock the mysteries of breast cancer."

"DNA Genotek is pleased to join forces with the Roswell Park Cancer Institute to collect samples on-site at the Western New York Race for the Cure event," said Ian Curry, President and CEO, DNA Genotek. "One of our primary goals is to deliver high quality products for researchers and clinicians all over the world to advance disease research, prevention and treatment. We are so pleased to assist in the collection of DNA samples at this event and we're proud of our long-term association with the successful Susan G. Komen Spit for the Cure events."

About the Roswell Park Cancer Institute:
Roswell Park Cancer Institute (RPCI) was established in 1898 on the principle of integrating clinical cancer care, cancer research and cancer education. RPCI was established as one of the first of the Comprehensive Cancer Centers by the National Cancer Institute (NCI) in 1974 and has held this designation continuously, since that time. RPCI is one of only a handful of free-standing NCI-designated comprehensive cancer centers in the country. The sole mission of the Institute is cancer research, treatment, prevention and education. The Institute devotes all of its resources, personnel, and facilities to supporting its cancer mission. For more information about the Roswell Park Cancer Institute, visit

About DNA Genotek:
DNA Genotek focuses on providing high-quality biological sample collection products. The company's lead product, the Oragene•DNA Self-Collection Kit, is the easiest way to collect and preserve large amounts of DNA from saliva. Oragene•DNA's reliability and ease-of-use have resulted in rapid adoption at top-tier health research institutions globally, including Harvard, Stanford, Cambridge, and Johns Hopkins. DNA Genotek markets its products worldwide and has established a global customer base in over 85 countries. For more information about DNA Genotek, visit

® Oragene is a registered trademark of DNA Genotek, Inc.
® Race for the Cure is a registered trademark of the Susan G. Komen for the Cure Foundation.
™ "Spit for the Cure" is a trademark of the Susan G. Komen for the Cure Organization.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Elsevier and NextBio Sign Partnership to Enrich ScienceDirect Content, Accelerating Life Sciences, Health Sciences and Chemistry Research
2. Optimal Reading Services Group, Inc. Receives Investment from Health Evolution Partners
3. Microfluidics Expands Distributorship in Japan with Exclusive POWREX Partnership to Meet Increased Demand in Pharmaceutical, Biotechnology and Energy Industries
4. AvePoint and OBS Forge Partnership
5. Neogen Partners With Chinese Government
6. Exiqon Diagnostics Partners With MedTrust Online to Promote KRAS Mutation Analysis and Other Innovative Molecular Oncology Diagnostic Services to Oncologists
7. ImmunoVaccine Technologies Partners with FIT Biotech to advance a therapeutic HIV vaccine
8. Leaders in Health Literacy Recognized by the Partnership for Clear Health Communication at the National Patient Safety Foundation
9. Catalyst Pharmaceutical Partners Receives NASDAQ Deficiency Notice
10. The Hamner Institutes Announce Partnership With China Medical City
11. LS9 and Procter & Gamble Launch Sustainable Chemicals Partnership
Post Your Comments:
(Date:11/30/2015)... Spherix Incorporated (Nasdaq: SPEX ) an ... and monetization of intellectual property, today provided an ... to create shareholder value. Anthony ... on published reports, the total addressable market of ... Spherix will seek to secure fair and reasonable ...
(Date:11/30/2015)... , Nov. 30, 2015  Champions Oncology, Inc. ... and services to personalize the development and use of ... Chief Executive Officer, will be presenting at the LD ... 4:30pm Pacific Standard Time (PST).  The conference, held at ... Los Angeles, CA , will feature 200 small/micro-cap ...
(Date:11/30/2015)... 2015 TapImmune, Inc. (TPIV), ... innovative peptide and gene-based immunotherapeutics and vaccines for the ... will be presenting at the 8 th Annual ... 2.30 PM PT. Dr. John N. Bonfiglio ... giving the presentation and will join TapImmune management in ...
(Date:11/30/2015)... Colo. , Nov. 30, 2015  Aytu BioScience, ... on urological and related conditions, will present at two ... at, an interactive real-time virtual conference, to be ... Event Investor Conference, to be held December 2 nd ... Los Angeles and streamed live via webcast. ...
Breaking Biology Technology:
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/9/2015)... Nov. 9, 2015  Synaptics Inc. (NASDAQ: SYNA ... announced broader entry into the automotive market with a ... the pace of consumer electronics human interface innovation. Synaptics, ... ideal for the automotive industry and will be implemented ... Europe , Japan , ...
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
Breaking Biology News(10 mins):